$CTSO News

Last published 7h ago

7h agoCTSOCytoSorbents Reports Third Quarter 2026 Financial Results, Achieves Operating Cash Flow Breakeven, and Provides Business and Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
7h agoCTSOCytosorbents Corp - PRESS RELEASE OF THE COMPANY, DATED NOVEMBER 12, 2026Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
3d agoCTSOCytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
2w agoCTSOCytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business HighlightsPR NewswirePRINCETON, N.J., Oct. 29, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification,
1mo agoCTSOCytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical CarePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1mo agoCTSOCytoSorbents Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
2mo agoCTSOCytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
2mo agoCTSOCytoSorbents Announces Reverse Stock SplitPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
2mo agoCTSOCytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission MeetingsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
3mo agoCTSOCytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
3mo agoCTSOCytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
4mo agoCTSOCytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026GlobeNewswirePRINCETON, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
6mo agoCTSOCytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
6mo agoCTSOCytoSorbents to Report First Quarter 2026 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
7mo agoCTSOCytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
7mo agoCTSOCytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
8mo agoCTSOCytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
10mo agoCTSOCytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
11mo agoCTSOTransforming Critical Care: CytoSorbents Blood-Purification Programs - CYTOSORBENTS CORPEarnings Call TranscriptsGood. Good morning, everyone. My name is Jason Colbert. I am the Senior Biotechnology Analyst, really the Senior Healthcare Analyst at D. Burrell Capital. One of the companies that I've been following for got to be 10, m
11mo agoCTSOCytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
12mo agoCTSOUpdated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
12mo agoCTSOCytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Participate at the Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOIn Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical OfficerPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in CopenhagenPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Provides DrugSorb-ATR Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis DayPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytosorbents Corporation (CTSO) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoCTSOCytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Leads a New Era in Sepsis TreatmentPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
1y agoCTSOCytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents to Participate at the Jefferies Global Healthcare ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Provides Regulatory Update for DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
1y agoCTSOCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer ProgramPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate ControllerPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Extends Expiration Date of Outstanding Series B Right WarrantsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual AuditPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
1y agoCTSOCytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate ControllerGlobeNewswirePRINCETON, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
1y agoCTSOCytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsGlobeNewswirePRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
1y agoCTSOCytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right WarrantsGlobeNewswirePRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood